Novo Nordisk Predicts Strong Second Half todayheadline
Here's our initial take on Novo Nordisk's (NVO 3.30%) fiscal 2025 first-quarter financial report. Key Metrics Metric (all figures in ...
Read moreDetailsTag: Novo
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide todayheadline
Eli Lilly has a plan to dominate the GLP-1 weight loss drug market -- and it's succeeding. It's Thursday morning, ...
Read moreDetailsWhy Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped todayheadline
There's a price war brewing in GLP-1 weight loss drugs, and now it's going global. Novo Nordisk (NVO -2.06%) stock ...
Read moreDetails
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear. todayheadline
Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the ...
Read moreDetailsBetter Buy: Eli Lilly or Novo Nordisk? todayheadline
In this video, I will cover the recent updates regarding Novo Nordisk (NYSE: NVO) and whether or not the dip ...
Read moreDetails
